We are an NCI-designated research center that moves laboratory discoveries into viable patient treatment options. Our research saves lives. We have been involved in the development of multiple cancer therapies now used worldwide. Our research scientists work with our clinical care physicians to develop cutting-edge therapies for our patients and their families. We train the next generation of cancer researchers through post-doctoral, graduate and college programs and high school mentorships.
This conference is a comprehensive summary of the most up-to-date research and clinical data presented at the 2018 American Society of Clinical Oncology’s (ASCO®) Annual Meeting. Topics to be presented include Palliative and Supportive Care, Neuro Oncology, Breast Cancer-Metastatic, Hematologic Malignancies, Lung Cancer/Thoracic, Gastrointestinal Cancers, New Therapeutics, Gynecology Oncology, GU Oncology, and Breast Oncology-Adjuvant.
Description: Yoga has been shown to increase physical fitness while reducing stress and anxiety. This weekly gentle yoga class focuses on flexibility, balance and proper breathing techniques. Wear comfortable clothing. Mats available but bring your own if you prefer.
Location: Mays Cancer Center 1st floor Library, Grossman Building 7979 Wurzbach Road San Antonio, TX 78229...
A registered massage therapist provides 15-minute chair massages for patients (with doctor's permission) or caregivers free of charge. Massages are $10 for others. Call 210-450-5570 to schedule your appointment.
Location: Mays Cancer Center 1st floor Grossman Library 7979 Wurzbach Road San Antonio, TX 78229...
Patrick Sung, D.Phil. (Courtesy, Yale University)
The Cancer Prevention & Research Institute of Texas (CPRIT) has awarded $6 million to UT Health San Antonio to support the recruitment of internationally known biochemist Patrick Sung, D.Phil. view more
A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.
The results of the trial were published May 8, 2018, in the Journal of the American Medical Association. Robert Svatek, M.D., a UT Health San Antonio genitourinary oncologist, was the university’s study leader. view more
Virginia G. Kaklamani, M.D., professor of hematology/oncology at the Mays Cancer Center and leader of the center’s breast cancer program, was born and reared in Athens, Greece, where both her parents were physicians.
Read her story view more
"We are delighted to honor the Mays Cancer Center for its 40 years of life-changing work and support its aspirations for the future."Lowry Mays, San Antonio community leader and donor to the Mays Cancer Center